About Regeneron
regeneron.com- Founded 1988
- Ticker REGN
- Revenue (FY2025) $14.34B
- Net income $4.50B
Investor research: Yahoo Finance · SEC filings
Source: Wikipedia
Regeneron
Regeneron is seeking a Medical Representative (MR) – Dermatology to join their Dupixent ROW Commercial Team in Japan. The role involves driving dermatology sales objectives, developing territory business plans, and delivering value to healthcare professionals and patients.
Requirements
- Bachelor’s degree (or equivalent)
- At least five years of sales representative experience in the pharmaceutical industry
- Valid driver’s license
- MR certification
Benefits
- Health and wellness programs
- Fitness centers
- 401(k) company match
- Family support benefits
- Equity awards
- Annual bonuses
- Paid time off
- Paid leaves (e.g., military and parental leave)
Originally posted on Himalayas
To apply for this job please visit himalayas.app.
Working in Japan
Japan is an island country in East Asia. Located in the Pacific Ocean off the northeast coast of the Asian mainland, it is bordered to the west by the Sea of Japan and extends from the Sea of Okhotsk in the north to the East China Sea in the south. The Japanese archipelago consists of four major islands alongside 14,121 smaller islands. Japan is divided into 47 administrative prefectures and eight traditional regions, and around 75% of its terrain is mountainous and heavily forested, concentrating its agriculture and highly urbanized population along its eastern coastal plains. With a populati
What people say about Regeneron
- An effective eye drug is $50, but many doctors choose a $2,000 alternative
- Hospitals and universities repurposing drugs at lower cost
- FDA approves first gene therapy for treatment of genetic hearing loss
- FDA approves first gene therapy for treatment of genetic hearing loss
Recent news
- Regeneron pays $37M, adds $2B in biobucks to expand CytomX pact - Fierce Biotech
- A man for all markets returns to the Regeneron Science Talent Search - Society for Science
- How One Partnership Profit Line Reframes The Regeneron Pharmaceuticals Stock Story - Trefis
- Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy Now? - Yahoo Finance
- Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Aggregated from public discussions and news; opinions are the authors’ own.
More jobs at Regeneron
Keep exploring on Get A Job.ai
Not quite the right fit? Your next opportunity is a click away.
- Browse all jobs
- More jobs by category
- Remote jobs you can do from anywhere
- Research typical pay for this role
- Set a job alert so new matches reach you first
- Upload your resume to apply faster
Hiring instead? Post a job and reach candidates searching right now.